Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Effect of radioiodine on stimulatory activity of Graves' immunoglobulins.

Atkinson S, McGregor AM, Kendall-Taylor P, Peterson MM, Smith BR.

Clin Endocrinol (Oxf). 1982 Jun;16(6):537-43.

PMID:
6125279
2.

Long-term effects of radioiodine on thyrotrophin receptor antibodies in Graves' disease.

Aizawa Y, Yoshida K, Kaise N, Kaise K, Fukazawa H, Kiso Y, Mori K, Sayama N, Kikuchi K, Abe K.

Clin Endocrinol (Oxf). 1995 May;42(5):517-22.

PMID:
7621571
4.

Immunological findings and thyroid function of untreated Graves' disease patients with undetectable TSH-binding inhibitor immunoglobulin.

Mukuta T, Tamai H, Oshima A, Morita T, Matsubayashi S, Fukata S, Kuma K.

Clin Endocrinol (Oxf). 1994 Feb;40(2):215-9.

PMID:
7907955
5.

Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.

Eckstein AK, Plicht M, Lax H, Hirche H, Quadbeck B, Mann K, Steuhl KP, Esser J, Morgenthaler NG.

Clin Endocrinol (Oxf). 2004 Nov;61(5):612-8.

PMID:
15521965
8.

The effect of subtotal thyroidectomy with propranolol preparation on antibody activity in Graves' disease.

Steel NR, Taylor JJ, Young ET, Farndon JR, Holcombe M, Kendall-Taylor P.

Clin Endocrinol (Oxf). 1987 Jan;26(1):97-106.

PMID:
3802553
9.

The relationships between serum T3 index, thyroid volume, and thyroid stimulating, TSH receptor binding and thyroid growth stimulating antibodies in untreated Graves' disease.

Bliddal H, Hegedüs L, Hansen JM, Bech K, van der Gaag R, Drexhage HA.

Clin Endocrinol (Oxf). 1987 Jul;27(1):75-84.

PMID:
2888551
10.

The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease: prevalence, mechanism and prognosis.

Aizawa Y, Yoshida K, Kaise N, Fukazawa H, Kiso Y, Sayama N, Hori H, Abe K.

Clin Endocrinol (Oxf). 1997 Jan;46(1):1-5.

PMID:
9059550
11.

Comparison between thyroid stimulating and tsh-binding inhibiting immunoglobulins of Graves' disease.

Macchia E, Fenzi GF, Monzani F, Lippi F, Vitti P, Grasso L, Bartalena L, Baschieri L, Pinchera A.

Clin Endocrinol (Oxf). 1981 Aug;15(2):175-82.

PMID:
6118213
13.

[The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].

Chen W, Man N, Li YS, Shan ZY, Teng WP.

Zhonghua Nei Ke Za Zhi. 2006 Feb;45(2):95-9. Chinese.

PMID:
16624113
14.

A study of untreated Graves' patients with undetectable TSH binding inhibitor immunoglobulins and the effect of anti-thyroid drugs.

Kawai K, Tamai H, Matsubayashi S, Mukuta T, Morita T, Kubo C, Kuma K.

Clin Endocrinol (Oxf). 1995 Nov;43(5):551-6.

PMID:
8548939
15.

Effects of radioiodine on thyrotrophin binding inhibiting immunoglobulins in Graves' disease.

McGregor AM, Petersen MM, Capiferri R, Evered DC, Smith BR, Hall R.

Clin Endocrinol (Oxf). 1979 Oct;11(4):437-44.

PMID:
583262
17.

Thyroid stimulating immunoglobulins in patients in long-term remission after Graves' disease.

Bliddal H, Bech K, Kirkegaard C.

Horm Metab Res. 1984 Nov;16(11):602-5.

PMID:
6210237
18.

The role of thyroid stimulating antibody (TSAb) in the thyroid function of patients with post-partum hypothyroidism.

Hara T, Tamai H, Mukuta T, Fukata S, Kuma K.

Clin Endocrinol (Oxf). 1992 Jan;36(1):69-74.

PMID:
1348451
19.

Paired determination of thyroid-stimulating and TSH-binding inhibitory activities in patients with Graves' disease during antithyroid drug treatment.

Kasagi K, Iida Y, Konishi J, Misaki T, Arai K, Endo K, Torizuka K, Kuma K.

Acta Endocrinol (Copenh). 1986 Apr;111(4):474-80.

PMID:
2422860
20.

Studies on thyrotrophin receptor antibodies in patients with euthyroid Graves' disease.

Kasagi K, Hatabu H, Tokuda Y, Iida Y, Endo K, Konishi J.

Clin Endocrinol (Oxf). 1988 Oct;29(4):357-66.

PMID:
2908031

Supplemental Content

Support Center